Comparison of QT Interval between Neonates with Maternal Gestational Diabetes and Healthy Mothers

Document Type : Original Article


1 Children’s and Neonatal Health Research Center, Golestan University of Medical Sciences, Gorgan, Iran

2 Golestan University of Medical Sciences, Gorgan, Iran


Background: The risk of developing metabolic syndrome and diseases, such as diabetes mellitus, has been increased as a worldwide rise in obesity. Gestational diabetes mellitus (GDM) or maternal hyperglycemia is a risk factor for cardiac dysfunction in neonates. The present study compared the QT interval in neonates with maternal GDM and healthy mothers.
Methods: This case-control study was carried out on term neonates with maternal GDM (case group; n=42) and healthy non-diabetic mothers (control group; n=42) in Sayyad-e-Shirazi hospital in Gorgan, Northeast of Iran, within March 2016 and February 2017. A pediatric cardiologist evaluated septal hypertrophy by Doppler echocardiography (Zonare ZS3) during the first 2 weeks after birth. A standard 12-lead electrocardiogram was recorded for 10 sec, and a corrected QT (QTc) value was calculated. The data were analyzed by the latest version of SPSS software (version 16) using the Chi-square and t-test for the assessment of the differences in the QT values and other indices between the two groups. P-values less than 0.05 were considered statistically significant.
Results: The results of the present study showed congenital heart diseases (CHDs) in six neonates. Significantly higher QT (249±36 and 245± 28 ms), septal thickness (6.09±1.07 and 5±1 mm), and lower QTc value (382±44.06 and 392± 34 ms) were observed in the case group, compared to those reported for the control group (p <0.001). The QTc dispersion was significantly different between the subjects under insulin therapy and participants receiving an antihyperglycemic oral regimen.
Conclusion: In this study, significant thicker cardiac septum and higher QT interval were observed in the neonates born from mothers with GDM in comparison to those from healthy mothers. This could suggest close cardiac monitoring of these neonates due to the higher probability of CHDs.


  1. Billionnet C, Mitanchez D, Weill A, Nizard J, Alla F, Hartemann A, et al. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Diabetologia. 2017; 60(4):636-44.
  2. Hay WW. Care of the infant of the diabetic mother. Curr Diab Rep. 2012; 12(1):4-15.
  3. Mitanchez D, Yzydorczyk C, Simeoni U. What neonatal complications should the pediatrician be aware of in case of maternal gestational diabetes? World J Diabetes. 2015; 6(5):734-43.
  4. Mackin ST, Nelson SM, Kerssens JJ, Wood R, Wild S, Colhoun HM, et al. Diabetes and pregnancy: national trends over a 15 year period. Diabetologia. 2018; 61(5):1081-8.
  5. Kulkarni A, Li L, Craft M, Nanda M, Lorenzo J, Danford D, et al. Fetal myocardial deformation in maternal diabetes mellitus and obesity. Ultrasound Obstet Gynecol. 2017; 49(5):630-6.
  6. Di Bernardo S, Mivelaz Y, Epure AM, Vial Y, Simeoni U, Bovet P, et al. Assessing the consequences
    of gestational diabetes mellitus on offspring’s cardiovascular health: MySweetHeart Cohort study protocol, Switzerland. BMJ Open. 2017; 7(11):
  7. Horsch A, Gilbert L, Lanzi S, Gross J, Kayser B, Vial Y, et al. Improving cardiometabolic and mental health in women with gestational diabetes mellitus and their offspring: study protocol for MySweetHeart Trial, a randomised controlled trial. BMJ Open. 2018; 8(2):e020462.
  8. Turhan U, Yilmaz E, Gul M, Melekoglu R, Turkoz Y, Ozyalin F, et al. Investigation of the effect of gestational diabetes on fetal cardiac tissue in streptozotocin ınduced in rats. Acta Cir Bras. 2018; 33(4):306-13.
  9. Basu M, Garg V. Maternal hyperglycemia and fetal cardiac development: clinical impact and underlying mechanisms. Birth Defects Res. 2018; 110(20):

10. Arslan D, Guvenc O, Cimen D, Ulu H, Oran B. Prolonged QT dispersion in the infants of diabetic mothers. Pediatr Cardiol. 2014; 35(6):1052-6.

11. Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is “normal”. J Cardiovasc Electrophysiol. 2006; 17(3):333-6.

12. Ren Y, Zhou Q, Yan Y, Chu C, Gui Y, Li X. Characterization of fetal cardiac structure and function detected by echocardiography in women with normal pregnancy and gestational diabetes mellitus. Prenat Diagn. 2011; 31(5):459-65.

13. Hăşmăşanu MG, Bolboacă SD, Matya M, Zaharie GC. Clinical and echocardiographic findings in newborns of diabetic mothers. Acta Clin Croat. 2015; 54(4.):458-66.

14. Garg S, Sharma P, Sharma D, Behera V, Durairaj M, Dhall A. Use of fetal echocardiography for characterization of fetal cardiac structure in women with normal pregnancies and gestational diabetes mellitus. J Ultrasound Med. 2014; 33(8):1365-9.

15. Sirico A, Lanzone A, Mappa I, Sarno L, Słodki M, Pitocco D, et al. The role of first trimester fetal heart rate in the prediction of gestational diabetes: a multicenter study. Eur J Obstet Gynecol Reprod Biol. 2019; 243:158-61.

16. Mohsin M, Sadqani S, Younus K, Hoodbhoy Z, Ashiqali S, Atiq M. Evaluation of cardiac function in fetuses of mothers with gestational diabetes. Cardiol Young. 2019; 29(10):1264-7.

17. Bhorat I, Pillay M, Reddy T. Assessment of the fetal myocardial performance index in well-controlled gestational diabetics and to determine whether it is predictive of adverse perinatal outcome. Pediatr Cardiol. 2019; 40(7):1460-7.

18. Dervisoglu P, Kosecik M, Kumbasar S. Effects of gestational and pregestational diabetes mellitus on the foetal heart: a cross-sectional study. J Obstet Gynaecol. 2018; 38(3):408-12.

19. Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 2019; 16(8):e1002848.